Tekla Life Sciences Investors
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
4.96 | 63.07 | -92.13% | 6.34 | -21.71% |
| P/S |
|
4.88 | 3.56 | 37.2% |
|
|
| P/BV |
|
0.9204 | 1.45 | -36.31% |
|
|
| P/FCF |
|
0 | -0.214 | -100% |
|
|
| Ev/Ebitda |
|
14.85 | -78.78 | -118.85% |
|
|
| Ev/S |
|
4.88 | 3.73 | 30.87% |
|
|
| Ev/FCF |
|
0 | -1.46 | -100% |
|
|
| E/P |
|
0 | -83.79 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
95.02 | 24.48 | 288.2% | 99.08 | -4.09% |
| ROE |
|
19.8 | 11 | 80.02% |
|
|
| ROA |
|
19.76 | 3.22 | 514.61% |
|
|
| ROIC |
|
0 | 5.17 | -100% |
|
|
| ROS |
|
98.4 | 19.04 | 416.92% |
|
|
| ROCE |
|
5.56 | -1.03 | -639.64% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -111.43 | -100% | 0.0041 | -100% |
| Nеt Debt/Ebitda |
|
0 | -51.39 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1734 | -100% |
|
|
| Debt/Equity |
|
0 | 117.92 | -100% |
|
|
| Debt/Net Income |
|
0 | 20.09 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
10.2 | 2.65 | 284.37% | 9.37 | +8.88% |
| Number of years of dividend growth |
|
0 | 5.08 | -100% | ||
| DSI |
|
0.8571 | 0.8639 | -0.7775% |
|
|
| Average dividend growth |
|
0.1723 | -5.47 | -103.15% |
|
|
| Average percentage for 5 years |
|
9.37 | 3.47 | 169.76% |
|
|
| Average percentage for payments |
|
27.12 | 71.83 | -62.24% |
|
|
| Difference from average difference in sector |
|
7.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-30.15 | 268.58 | -111.23% | ||
| Growth impulse Ebitda in 5 years |
|
-131.71 | 26.9 | -589.63% | ||
| Growth impulse Net Income in 5 years |
|
-30.71 | 186.01 | -116.51% | ||
| Growth impulse FCF in 5 years |
|
-349.12 | -478.53 | -27.04% | ||
| Growth impulse EPS in 5 years |
|
-41.09 | 2201.18 | -101.87% |
IP Score
6.1/10
